<DOC>
	<DOCNO>NCT01320137</DOCNO>
	<brief_summary>The purpose study develop characterize immunological assay blood sample .</brief_summary>
	<brief_title>Study Allergic Adults Support Development Immunological Assays</brief_title>
	<detailed_description>This clinical study vaccine administer . It design research purpose develop immunological assay .</detailed_description>
	<criteria>Subjects investigator believe comply requirement protocol . Written inform consent obtain subject . Healthy subject ( except condition study ALLERGY group ) . A male female , include 18 45 year age time study start . Subject present moderate severe clinical symptom allergy within week enrolment ( ALLERGY group ) . Subjects suffer seasonal allergy birch pollen previously document medical history ( ALLERGY group ) . A positive skin prick test response realise and/or positive test specific IgE birch within last 5 year ( ALLERGY group ) . Any known clinical sign anaemia condition would preclude draw blood describe protocol . Receipt blood product 120 day prior study visit . Receipt immunoglobulin 120 day prior study visit . Use investigational nonregistered product within 30 day precede study visit . Concurrently participate another clinical study , time study visit , subject expose investigational noninvestigational product . Any confirm suspected immunosuppressive immunodeficient condition , base medical history . Any confirm suspect autoimmune inflammatory disorder . Administration systemic inhaled antiinflammatory medication , particular , inhaled corticoidsteroids cromoglycates within 30 day precede study visit . Purely local medication intranasal steroid systemic symptomatic medication antihistamine beta agonist allow . Chronic administration immunosuppressant immunemodifying drug within six month prior study visit . Pregnant lactate female . Any past current birchspecific immunotherapy ( ALLERGY group ) . Any allergic disease establish medical history study start ( CONTROL group ) . Family history allergic disease first degree family member ( CONTROL group ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Immunological assay</keyword>
	<keyword>Birch allergy</keyword>
</DOC>